Join
Live feed
·
SECFilingvia Quantisnow
Nektar Therapeutics logo

Nektar Therapeutics filed SEC Form 8-K: Termination of a Material Definitive Agreement, Entry into a Material Definitive Agreement, Other Events

ByQuantisnow·Wall Street's wire, on your screen.
NKTR· Nektar Therapeutics
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NKTR (Nektar Therapeutics) and more on Quantisnow.